Wednesday, July 29, 2015

Massless particle discovered

After 85 years of searching, researchers have confirmed the existence of a massless particle called the Weyl fermion for the first time ever. With the unique ability to behave as both matter and anti-matter inside a crystal, this strange particle can create electrons that have no mass.
The discovery is huge, not just because we finally have proof that these elusive particles exist, but because it paves the way for far more efficient electronics, and new types of quantum computing. "Weyl fermions could be used to solve the traffic jams that you get with electrons in electronics - they can move in a much more efficient, ordered way than electrons," lead researcher and physicist M. Zahid Hasan from Princeton University in the US told Anthony Cuthbertson over at IBTimes
Electrons are the backbone of today's electronics, and while they carry charge pretty well, they also have the tendency to bounce into each other and scatter, losing energy and producing heat. But back in 1929, a German physicist called Hermann Weyl theorised that a massless fermion must exist, that could carry charge far more efficiently than regular electrons. 
And now the team at Princeton has shown that they do indeed exist. In fact, they've shown that in a test medium, Weyl electrons can carry charge at least 1,000 times faster than electrons in ordinary semiconductors, and twice as fast as inside wonder-material graphene.
They're also far more efficient than electrons, the team reports in Sciencebecause the particle's spin is both in the same direction as its motion (which physicists call 'right-handed) and opposite its direction ('left-handed') at the same time. This means that all the fermions move in exactly the same way and can traverse through and around obstacles that scatter normal electrons.
"It's like they have their own GPS and steer themselves without scattering," Hasan said in a press release. "They will move and move only in one direction since they are either right-handed or left-handed and never come to an end because they just tunnel through. These are very fast electrons that behave like unidirectional light beams and can be used for new types of quantum computing." 
What's particularly cool about the discovery is that the researchers found the Weyl fermion in a synthetic crystal in the lab, unlike most other particle discoveries, such as the famous Higgs boson, which are only observed in the aftermath of particle collisions. This means that the research is easily reproducible, and scientists will be able to immediately begin figuring out how to use the Weyl fermion in electronics.
The team found the particle after specially formulating a semi-metal crystal called tantalum arsenide, which had previously been flagged by researchers in China as a potential 'home' for the Weyl fermion. After finding traces of the elusive particle in their lab, they took the crystals to the Lawrence Berkeley National Laboratory in California, where they fired high-energy photon beams through them. The signature of the beams on the other side confirmed that the crystals did indeed contain the Weyl fermion.
Weyl fermions are what's known as quasiparticles, which means they can only exist in a solid such as a crystal, and not as standalone particles. But further research will help scientists work out just how useful they could be. "The physics of the Weyl fermion are so strange, there could be many things that arise from this particle that we're just not capable of imagining now," said Hasan.

Friday, July 17, 2015

Scientists create new algae that tastes like bacon

Oregon State University researchers created and patented a new strain of the protein-rich red marine algae known as Dulse. When cooked, this new stuff really tastes like bacon. The engineered strain is high in protein, and purportedly offers twice the nutritional value of everyone's favorite vegetable-du-jour, kale.
Dulse (Palmaria sp.) grows in the wild along the Pacific and Atlantic coastlines. It is harvested and usually sold for up to $90 a pound in dried form as a cooking ingredient or nutritional supplement. But researcher Chris Langdon and colleagues at OSU’s Hatfield Marine Science Center have created and patented a new strain of dulse – one he has been growing for the past 15 years.
This strain, which looks like translucent red lettuce, is an excellent source of minerals, vitamins and antioxidants – and it contains up to 16 percent protein in dry weight, Langdon said.

We can only hope the next strain they make tastes like pizza


For science!!

source:http://oregonstate.edu/ua/ncs/archives/2015/jul/osu-researchers-discover-unicorn-–-seaweed-tastes-bacon

Friday, September 5, 2014

Scientists Discover Effective Strategy To Switch Off Autoimmunity

A new study has shed light on a poorly understood therapy developed to treat individuals with autoimmune diseases. The researchers not only revealed the molecular mechanisms behind the therapy, but also identified an optimal strategy that will reduce treatment-associated risks and result in long-term modulation of rogue immune system cells. The work has been published in Nature Communications.
Autoimmune diseases—such as multiple sclerosis, type 1 diabetes and rheumatoid arthritis—are chronic inflammatory conditions that result from the body’s immune cells inappropriately attacking healthy tissues. This happens because the immune system is unable to distinguish between your own tissue and potentially harmful substances.
Scientists have made progress in developing treatments for these diseases in recent years, but in order to be successful the treatments need to be long-lasting and should not affect normal immune function. A specific type of therapy called antigen-specific immunotherapyaims to tick these boxes and has been shown to work in some trials.
The therapy involves administering increasing doses of the molecules that the body normally attacks, which gradually builds up a tolerance to them. However, the best dose to create safe, long-term protection was unknown. Furthermore, scientists did not understand the underlying mechanisms that led to this tolerance. Now, a new study conducted by researchers at the University of Bristol has shed light on both of these areas, which will hopefully lead to more effective treatments.
For the current study, the researchers looked at a type of white blood cell called a CD4+ T cell—one of the most important players in autoimmunity. These cells usually help fight infection, but in individuals with autoimmune diseases they drive the immune response that results in inflammation.
The researchers administered increasing amounts of protein fragments that are normally the target for attack and looked at which genes were switched on inside the CD4 cells at different stages. They found that as the dose escalated, genes that positively regulate inflammation and cell cycle pathways were switched off. This caused the cells to convert from aggressive cells into protective cells. Furthermore, they identified the genes that characterize these CD4 cells.
From this, the researchers were able to develop an optimal dose escalation strategy that efficiently reinstates self-tolerance. This means that instead of attacking self tissues, the immune system gradually begins to ignore them. Importantly, this is achieved without the need for immunosuppressive drugs that have undesirable side effects, such as leaving the individual susceptible to infections and tumors.
“Insight into the molecular basis of antigen-specific immunotherapy opens up exciting new opportunities to enhance the selectivity of the approach while providing valuable markers with which to measure effective treatment,” lead researcher David Wraith said in a news release. “These findings have important implications for the many patients suffering from autoimmune conditions that are currently difficult to treat.”

Friday, August 29, 2014

progress against HIV

In an unexpected twist, a family of proteins that have been found to promote HIV-1 entry into cells also potently block viral release. Interestingly, these proteins were also found to inhibit the release of other viruses, including Ebola virus. These intriguing new findings provide us with novel insights into both viral infection and the development of AIDS, which could ultimately lead to new antiviral strategies. The study has been published in Proceedings of the National Academy of Sciences.
Viruses are unable to replicate by themselves and thus must hijack a host cell’s machinery in order to do so. To get inside host cells, HIV, or human immunodeficiency virus, needs to bind to receptors found on target cells. This triggers a series of events that ultimately lead to viral entry; once inside, HIV converts the cell into a factory for making more viruses.
Recent studies have identified a family of proteins, called TIM proteins, which play critical roles in facilitating the entry of various viruses including Ebola, West Nile and dengue viruses. Intriguingly, University of Missouri researchers have now discovered that these proteins not only promote HIV-1 entry into host cells, but they also prevent viral release.
For the study, scientists investigated the interactions between HIV-1 and TIM proteins using various molecular, biochemical and microscopic techniques. They found that as HIV-1 begins to bud from, or escape, the host cell, TIM proteins become incorporated into the virions and tether the particles to the cellular membrane. This is mediated through interactions with a lipid called phosphatidylserine (PS) that is found both on the cell membrane and the outside of the virus particles. Usually, PS is expressed on the inside of the cell, but viral infection causes it to flip to the outside, meaning that both PS and TIM are now present on the cell and viral surface. TIM and PS then bind to one another as HIV-1 attempts to escape from the cell, causing the particles to be retained at the cell surface.
Interestingly, the team also discovered that TIM proteins inhibited the release of other viruses including a mouse virus belonging to the same family as HIV (murine leukemia virus), and also Ebola virus.
view study here:http://www.pnas.org/content/early/2014/08/14/1404851111.abstract